Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Cross-reactivity in β-Lactam Allergy.

Zagursky RJ, Pichichero ME.

J Allergy Clin Immunol Pract. 2018 Jan - Feb;6(1):72-81.e1. doi: 10.1016/j.jaip.2017.08.027. Epub 2017 Oct 7.

PMID:
29017833
2.

Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection.

Fouts TR, Bagley K, Prado IJ, Bobb KL, Schwartz JA, Xu R, Zagursky RJ, Egan MA, Eldridge JH, LaBranche CC, Montefiori DC, Le Buanec H, Zagury D, Pal R, Pavlakis GN, Felber BK, Franchini G, Gordon S, Vaccari M, Lewis GK, DeVico AL, Gallo RC.

Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):E992-9. doi: 10.1073/pnas.1423669112. Epub 2015 Feb 13. Erratum in: Proc Natl Acad Sci U S A. 2015 May 5;112(18):E2413.

3.

Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease.

McNeil LK, Zagursky RJ, Lin SL, Murphy E, Zlotnick GW, Hoiseth SK, Jansen KU, Anderson AS.

Microbiol Mol Biol Rev. 2013 Jun;77(2):234-52. doi: 10.1128/MMBR.00056-12. Review.

4.

Application of genomics in bacterial vaccine discovery: a decade in review.

Zagursky RJ, Anderson AS.

Curr Opin Pharmacol. 2008 Oct;8(5):632-8. doi: 10.1016/j.coph.2008.06.009. Epub 2008 Jul 24. Review.

PMID:
18625342
5.

Proteomic analysis and identification of Streptococcus pyogenes surface-associated proteins.

Severin A, Nickbarg E, Wooters J, Quazi SA, Matsuka YV, Murphy E, Moutsatsos IK, Zagursky RJ, Olmsted SB.

J Bacteriol. 2007 Mar;189(5):1514-22. Epub 2006 Dec 1.

6.

Bioinformatics: how it is being used to identify bacterial vaccine candidates.

Zagursky RJ, Olmsted SB, Russell DP, Wooters JL.

Expert Rev Vaccines. 2003 Jun;2(3):417-36. Review.

PMID:
12903807
7.

Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci.

Dunman PM, Murphy E, Haney S, Palacios D, Tucker-Kellogg G, Wu S, Brown EL, Zagursky RJ, Shlaes D, Projan SJ.

J Bacteriol. 2001 Dec;183(24):7341-53.

8.

Bioinformatics: use in bacterial vaccine discovery.

Zagursky RJ, Russell D.

Biotechniques. 2001 Sep;31(3):636, 638, 640, passim. Review.

9.

Mining genomes and mapping proteomes: identification and characterization of protein subunit vaccines.

Chakravarti DN, Fiske MJ, Fletcher LD, Zagursky RJ.

Dev Biol (Basel). 2000;103:81-90. Review.

PMID:
11214257
10.

Application of genomics and proteomics for identification of bacterial gene products as potential vaccine candidates.

Chakravarti DN, Fiske MJ, Fletcher LD, Zagursky RJ.

Vaccine. 2000 Nov 8;19(6):601-12.

PMID:
11090710
11.
12.

Quantitation of cellular receptors by a new immunocytochemical flow cytometry technique.

Zagursky RJ, Sharp D, Solomon KA, Schwartz A.

Biotechniques. 1995 Mar;18(3):504-9.

PMID:
7779403
13.

Construction of infectious molecular clones of HIV-1 containing defined mutations in the protease gene.

Winslow DL, Anton ED, Horlick RA, Zagursky RJ, Tritch RJ, Scarnati H, Ackerman K, Bacheler LT.

Biochem Biophys Res Commun. 1994 Dec 30;205(3):1651-7.

PMID:
7811249
14.

Detection of single base differences using biotinylated nucleotides with very long linker arms.

Livak KJ, Hobbs FW, Zagursky RJ.

Nucleic Acids Res. 1992 Sep 25;20(18):4831-7.

15.

Use of 33P for Sanger DNA sequencing.

Zagursky RJ, Conway PS, Kashdan MA.

Biotechniques. 1991 Jul;11(1):36, 38.

PMID:
1954015
16.

In vitro production of large single-stranded templates for DNA sequencing.

Straus NA, Zagursky RJ.

Biotechniques. 1991 Mar;10(3):376-84.

PMID:
1648367
17.

Improvements in the chain-termination method of DNA sequencing through the use of 7-deaza-2'-deoxyadenosine.

Jensen MA, Zagursky RJ, Trainor GL, Cocuzza AJ, Lee A, Chen EY.

DNA Seq. 1991;1(4):233-9.

PMID:
1806040
18.

DNA sequencing separations in capillary gels on a modified commercial DNA sequencing instrument.

Zagursky RJ, McCormick RM.

Biotechniques. 1990 Jul;9(1):74-9.

PMID:
2393576
19.

Mutational analysis of the lambda int gene: DNA sequence of dominant mutations.

Bear SE, Clemens JB, Enquist LW, Zagursky RJ.

J Bacteriol. 1987 Dec;169(12):5880-3.

20.

A system for rapid DNA sequencing with fluorescent chain-terminating dideoxynucleotides.

Prober JM, Trainor GL, Dam RJ, Hobbs FW, Robertson CW, Zagursky RJ, Cocuzza AJ, Jensen MA, Baumeister K.

Science. 1987 Oct 16;238(4825):336-41.

PMID:
2443975
21.

A shuttle vector plasmid for studying carcinogen-induced point mutations in mammalian cells.

Seidman MM, Dixon K, Razzaque A, Zagursky RJ, Berman ML.

Gene. 1985;38(1-3):233-7.

PMID:
2998945
22.
23.
24.

Supplemental Content

Loading ...
Support Center